A new machine learning tool developed by Ohio State scientists may have just cracked the code. By analyzing over 1,000 blood samples, the platform—dubbed PANDA—can detect subtle shifts in metabolism linked to colorectal cancer and even its genetic risk factors. What makes it even more compelling? It might monitor how well treatments are working—before traditional methods catch up.
The tool isn’t meant to replace colonoscopies—yet. But could a few drops of blood eventually flag cancer’s earliest whispers? The future of diagnosis might just lie in your metabolism.